Trial
NCT04472494
Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Bristol-Myers Squibb
Collaborators
—
Condition
COVID-19
Intervention
Abatacept
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-10-07